Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell Lines
出版年份 2013 全文链接
标题
Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell Lines
作者
关键词
-
出版物
MOLECULES
Volume 18, Issue 12, Pages 15750-15768
出版商
MDPI AG
发表日期
2013-12-18
DOI
10.3390/molecules181215750
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthesis and Evaluation of Some 17-Acetamidoandrostane and N,N-Dimethyl-7-deoxycholic Amide Derivatives as Cytotoxic Agents: Structure/Activity Studies
- (2013) Yanmin Huang et al. MOLECULES
- Pharmacological Actions of Multi-Target-Directed Evodiamine
- (2013) Hui Yu et al. MOLECULES
- Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells
- (2013) Kai-Lee Wang et al. PLoS One
- Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells
- (2012) Jie Yang et al. CANCER LETTERS
- Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines
- (2012) Buxi Shi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
- (2012) Wei-Tian Wei et al. International Journal of Biological Sciences
- New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations
- (2012) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells
- (2012) Xiaobei Pan et al. PHYTOMEDICINE
- Synthesis and cytotoxicity of 17a-aza-d-homo-androster-17-one derivatives
- (2011) Yanmin Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents
- (2011) Zhiyong Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells
- (2010) Chun Zhang et al. ANTI-CANCER DRUGS
- Synthesis of novel β-carbolines with efficient DNA-binding capacity and potent cytotoxicity
- (2010) Zhiyong Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting apoptosis pathways in cancer by Chinese medicine
- (2010) Min Li-Weber CANCER LETTERS
- Synthesis and cytotoxic evaluation of 1-carboxamide and 1-amino side chain substituted β-carbolines
- (2010) Chunming Ma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Anti-Proliferative Effects of Evodiamine on Human Thyroid Cancer Cell Line ARO
- (2010) Meng-Ching Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents
- (2010) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antiproliferation and Apoptosis Induced by Evodiamine in Human Colorectal Carcinoma Cells (COLO-205)
- (2009) Zhi-Gang Yang et al. CHEMISTRY & BIODIVERSITY
- Evodiamine inhibits adipogenesis via the EGFR-PKCα-ERK signaling pathway
- (2009) Ting Wang et al. FEBS LETTERS
- Determination of drug-like properties of a novel antileishmanial compound: In vitro absorption, distribution, metabolism, and excretion studies
- (2009) NirupB Mondal et al. INDIAN JOURNAL OF PHARMACOLOGY
- Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia rutaecarpa
- (2009) Junlin Jiang et al. MOLECULES
- Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
- (2009) Agnes Chan et al. MOLECULES
- Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-κB signaling pathways and augmented by ubiquitin–proteasome inhibition
- (2009) Che Wang et al. TOXICOLOGY IN VITRO
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started